Agenus Inc
AGEN· Nasdaq
AGENAgenus Inc
Filed Mar 16, 2023 · 10-K · 75 days after period end · 0000950170-23-008517
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020 | Q4 2019 |
|---|---|---|---|---|
| Revenue | $28.39M | $20.26M | $31.27M | $34.50M |
| Net Income | -$74.10M | -$67.61M | -$37.73M | -$30.85M |
| EPS Diluted | — | — | -$0.20 | -$0.22 |
Agenus Inc · CIK 1098972 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2022 · filed Mar 16, 2023 · 75 d after period end
